Skip to main content
. 2024 Mar 27;384:e077169. doi: 10.1136/bmj-2023-077169

Fig 4.

Fig 4

Performance of the primary and simple models compared with three previous models. Top panel shows a comparison of the discrimination of the primary and simple models (Gupta et al) with three existing models (Bhat et al,13 de Jongh et al,14 and Motwani et al.23 for CP-AKI. DeLong P<0.001 for comparison of the Gupta et al models to each of the other three models. Bottom panel shows a comparison of the study characteristics and risk factors for CP-AKI identified in the Gupta et al models versus three previous models. *In the study by Motwani et al,23 development and validation cohorts were used, but patients were derived from two hospitals within the same integrated healthcare system. †In the study by de Jongh et al,14 female sex was associated with a higher risk of CP-AKI, whereas in the study by Bhat et al,13 male sex was associated with a higher risk. ‡Data on paclitaxel were not available in the current dataset. AUC=area under the curve; CI=confidence interval; CP-AKI=cisplatin associated acute kidney injury